Trial Search Results

Steroids After Laser Trabeculoplasty for Glaucoma

The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocular pressure (IOP).

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: University of Pittsburgh Medical Center

Stanford Investigator(s):

Intervention(s):

  • Drug: Prednisolone 1%
  • Drug: Ketorolac
  • Drug: Artificial Tears

Phase:

Phase 4

Eligibility


Inclusion Criteria:

   - clinical diagnosis of glaucoma

   - clinician has determined that SLT laser is indicated

   - IOP currently >18 and was ever >21 in the past (e.g. prior to treatment)

Exclusion Criteria:

   - prior history of uveitis

   - prior glaucoma surgery including glaucoma laser surgery

   - pregnant or 3 months post-partum

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting